Titel

Merkliste
1 Ergebnisse

Nivolumab plus rucaparib for metastatic castration-resistan..:

Fizazi, Karim ; Retz, Margitta ; Petrylak, Daniel P...
Journal for ImmunoTherapy of Cancer -- J Immunother Cancer -- 2051-1426. , 2022

Link: https://doi.org/10.1136/jitc-2022-004761

RT Journal
T1 <Title>Nivolumab plus rucaparib for metastatic castration-resistant prostate cancer: results from the phase 2 CheckMate 9KD trial</Title>

UL https://suche.suub.uni-bremen.de/peid=base-ftdbthueringen:oai:www.db-thueringen.de:dbt_mods_00053252&Exemplar=1&LAN=DE
				
A1 Fizazi, Karim
A1 Retz, Margitta
A1 Petrylak, Daniel P
A1 Goh, Jeffrey C
A1 Perez-Gracia, Jose
A1 Lacombe, Louis
A1 Zschäbitz, Stefanie
A1 Burotto, Mauricio
A1 Mahammedi, Hakim
A1 Gravis, Gwenaelle
A1 Bastos, Diogo Assed
A1 McCune, Steven L
A1 Vázquez Limón, Juan Carlos
A1 Kwan, Edmond M
A1 Castellano, Daniel
A1 Fléchon, Aude
A1 Saad, Fred
A1 Grimm, Marc-Oliver
A1 Shaffer, David R
A1 Armstrong, Andrew J
A1 Bhagavatheeswaran, Prabhu
A1 Amin, Neha P
A1 Ünsal-Kaçmaz, Keziban
A1 Wang, Xuya
A1 Li, Jun
A1 Loehr, Andrea
A1 Pachynski, Russell K
YR 2022
K1 article
K1 ScholarlyArticle
K1 ddc:610
K1 Clinical Trials
K1 Phase II as Topic
K1 Immunotherapy
JF Journal for ImmunoTherapy of Cancer -- J Immunother Cancer -- 2051-1426
LK http://dx.doi.org/https://doi.org/10.1136/jitc-2022-004761
DO https://doi.org/10.1136/jitc-2022-004761
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)